Attorney Kathy Hibbs will guide 23andMe as the firm seeks FDA approval for its personalized genomics product. Hibbs will manage the firm's regulatory strategy in her role as chief legal and regulatory officer. Hibbs has also worked for Genomic Health and represented The Personalized Medicine Coalition, an advocacy organization that educates policymakers about the benefits of personalized medicine.

Full Story:
Bio-IT World

Related Summaries